In recent years, it has been demonstrated that the TLR2/TLR4-NF-κB signaling pathway can be exploited as a target to reduce TLR2/TLR4 protein expression levels to cure gouty arthritis symptoms [16]. Here, TLR4 is linked to arthritic joint disease.